ST6GAL1 is associated with poor response to chemoradiation in rectal cancer
Introduction: Colorectal cancer is the third most common cause of cancer death. Rectal cancer makes up a third of all colorectal cases. Treatment for locally advanced rectal cancer includes chemoradiation followed by surgery. We have previously identified ST6GAL1 as a cause of resistance to chemorad...
Main Authors: | Mary Smithson, Sameer Al Diffalha, Regina K. Irwin, Gregory Williams, M. Chandler McLeod, Vivek Somasundaram, Susan L. Bellis, Karin M. Hardiman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-05-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558624000216 |
Similar Items
-
ST6Gal1: Oncogenic signaling pathways and targets
by: Sajina GC, et al.
Published: (2022-08-01) -
Systemic ST6Gal-1 Is a Pro-survival Factor for Murine Transitional B Cells
by: Eric E. Irons, et al.
Published: (2018-09-01) -
Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers
by: Jishun Lu, et al.
Published: (2015-04-01) -
Adipose microenvironment promotes hypersialylation of ovarian cancer cells
by: Alexandra Fox, et al.
Published: (2024-07-01) -
ST3Gal IV Mediates the Growth and Proliferation of Cervical Cancer Cells In Vitro and In Vivo Via the Notch/p21/CDKs Pathway
by: Yinshuang Wu, et al.
Published: (2021-02-01)